Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-05-28 @ 5:55 PM
Study NCT ID:
NCT00044135
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2002-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Sponsor:
Triangle Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
L-FMAU-102 B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None